170 related articles for article (PubMed ID: 23291777)
21. Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence.
Raju J; Swamy MV; Cooma I; Patlolla JM; Pittman B; Reddy BS; Steele VE; Rao CV
Int J Cancer; 2005 Feb; 113(5):798-802. PubMed ID: 15499611
[TBL] [Abstract][Full Text] [Related]
22. Chemopreventive evaluation of a Schiff base derived copper (II) complex against azoxymethane-induced colorectal cancer in rats.
Hajrezaie M; Hassandarvish P; Moghadamtousi SZ; Gwaram NS; Golbabapour S; Najihussien A; Almagrami AA; Zahedifard M; Rouhollahi E; Karimian H; Fani S; Kamalidehghan B; Majid NA; Ali HM; Abdulla MA
PLoS One; 2014; 9(3):e91246. PubMed ID: 24618844
[TBL] [Abstract][Full Text] [Related]
23. Pomegranate (Punica granatum) peel extract efficacy as a dietary antioxidant against azoxymethane-induced colon cancer in rat.
Waly MI; Ali A; Guizani N; Al-Rawahi AS; Farooq SA; Rahman MS
Asian Pac J Cancer Prev; 2012; 13(8):4051-5. PubMed ID: 23098515
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
Rao CV; Kawamori T; Hamid R; Reddy BS
Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
[TBL] [Abstract][Full Text] [Related]
25. Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon.
Morishita Y; Yoshimi N; Kawabata K; Matsunaga K; Sugie S; Tanaka T; Mori H
Jpn J Cancer Res; 1997 Sep; 88(9):815-20. PubMed ID: 9369928
[TBL] [Abstract][Full Text] [Related]
26. Brewers' rice modulates oxidative stress in azoxymethane-mediated colon carcinogenesis in rats.
Tan BL; Norhaizan ME; Huynh K; Yeap SK; Hazilawati H; Roselina K
World J Gastroenterol; 2015 Aug; 21(29):8826-35. PubMed ID: 26269672
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
28. Deoxycholic acid promotes the growth of colonic aberrant crypt foci.
Flynn C; Montrose DC; Swank DL; Nakanishi M; Ilsley JN; Rosenberg DW
Mol Carcinog; 2007 Jan; 46(1):60-70. PubMed ID: 17091474
[TBL] [Abstract][Full Text] [Related]
29. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells.
Patlolla JM; Raju J; Swamy MV; Rao CV
Mol Cancer Ther; 2006 Jun; 5(6):1459-66. PubMed ID: 16818504
[TBL] [Abstract][Full Text] [Related]
30. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
[TBL] [Abstract][Full Text] [Related]
31. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
[TBL] [Abstract][Full Text] [Related]
33. Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.
Pattananandecha T; Sirilun S; Duangjitcharoen Y; Sivamaruthi BS; Suwannalert P; Peerajan S; Chaiyasut C
Pharm Biol; 2016 Sep; 54(9):1596-605. PubMed ID: 26794346
[TBL] [Abstract][Full Text] [Related]
34. Effect of dietary caraway essential oils on expression of β-catenin during 1,2-dimethylhydrazine-induced colonic carcinogenesis.
Allameh A; Dadkhah A; Rahbarizadeh F; Ashrafi-Helan J; Fatemi F
J Nat Med; 2013 Oct; 67(4):690-7. PubMed ID: 22418855
[TBL] [Abstract][Full Text] [Related]
35. Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon.
Al-Numair KS; Waly MI; Ali A; Essa MM; Farhat MF; Alsaif MA
Exp Biol Med (Maywood); 2011 Sep; 236(9):1005-11. PubMed ID: 21768165
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of colonic aberrant crypt foci by Gynura procumbens in rats.
Shwter AN; Abdullah NA; Alshawsh MA; Alsalahi A; Hajrezaei M; Almaqrami AA; Salem SD; Abdulla MA
J Ethnopharmacol; 2014 Feb; 151(3):1194-1201. PubMed ID: 24393787
[TBL] [Abstract][Full Text] [Related]
37. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV
Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859
[TBL] [Abstract][Full Text] [Related]
38. Effect of 2-(carboxyphenyl) retinamide and genistein on the formation of early lesions in 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.
Zhi H; Yamada Y; Hirose Y; Kato K; Sheng H; Zheng Q; Oyama T; Asano N; Kuno T; Hara A; Mori H
Asian Pac J Cancer Prev; 2007; 8(1):33-8. PubMed ID: 17477768
[TBL] [Abstract][Full Text] [Related]
39. The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethane-induced aberrant crypt foci in rats.
Rouhollahi E; Moghadamtousi SZ; Al-Henhena N; Kunasegaran T; Hasanpourghadi M; Looi CY; Abd Malek SN; Awang K; Abdulla MA; Mohamed Z
Drug Des Devel Ther; 2015; 9():3911-22. PubMed ID: 26251570
[TBL] [Abstract][Full Text] [Related]
40. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
